Event Objectives:
- The purpose of this study was to provide work flow optimization in the EHR for pediatric residents and track time use metrics as well as resident satisfaction.
- Review results of largest single-center study looking at pediatric and young adult patients with IBD followed and seen in Connecticut Children's initially on Originator-Infliximab (Remicade) and switched to Biosimilar-Infliximab (Inflectra).
- To apply lung ultrasound scores to severity of neonatal lung disease.
- Interpret data that suggest safety and efficacy of subcutaneous estradiol for gender-affirming hormone treatment for transgender and gender diverse adolescents and young adults.